Their targeted gene was SLC20A2 whose mutations cause the familial idiopathic basal ganglia calcification (Fahr’s disease) molecularly demonstrated as deposits of calcium in basal ganglia and other distinct brain regions. Here, SLC20A2 is linked to Basal ganglia calcification.